오픈뉴스백과
세계의 오늘한국의 오늘라이브둘러보기뉴스ONP 브리핑
뉴스로 배우기커뮤니티회사학술과학정부용어사전피드 제보내 편향
...

오픈뉴스백과

집단지성 기반 뉴스 검증 플랫폼. 다양한 시각으로 뉴스를 이해합니다.

서비스

세계의 오늘한국의 오늘라이브뉴스정부과학학술용어사전소개

법적 고지

개인정보처리방침이용약관콘텐츠 이용 안내

문의

문의하기

본 플랫폼에서 제공하는 뉴스 콘텐츠의 저작권은 각 언론사에 있으며, 무단 복제 및 배포를 금지합니다.

RSS 피드를 통해 수집된 콘텐츠는 각 원저작자의 라이선스 조건을 따릅니다. 오픈 라이선스(CC-BY 등) 콘텐츠는 해당 라이선스에 따라 출처를 표기합니다.

오픈뉴스백과는 뉴스 집계 및 검증 플랫폼으로, 개별 기사의 내용에 대한 책임은 해당 언론사에 있습니다.

이용자가 작성한 피드백, 팩트체크, 독자 제보 등의 콘텐츠에 대한 책임은 해당 작성자에게 있습니다.

콘텐츠 제거·정정이 필요하시면 문의하기에 남겨 주세요.

© 2026 오픈뉴스백과 (OpenNewsPedia). All rights reserved.

🔬

과학

NASA·USGS·WHO 등 과학·연구·보건 기관의 공식 자료. Public Domain / WHO 라이선스로 본문 직접 표시.

총 38건

국가

전체
🇬🇧 영국 5,983
🇺🇸 미국 1,655
🌐 국제기구 38
🇰🇷 한국 2
🇯🇵 일본 1

발행처

전체WHO News (English)28UNEP (UN 환경)10
WHO News (English)

Global childhood immunization coverage inches forward despite conflict and hesitancy – UNICEF, WHO

In 2025, 90% of infants globally – or nearly 116 million – received at least one dose of a diphtheria, tetanus and pertussis (DTP) vaccine, and 85% – or 110 million – completed the full three-dose series, according to the annual WHO-UNICEF Estimates of National Immunization Coverage (WUENIC) released today.   While both indicators rose by one percentage point from the previous year, global coverage remains one point below 2019 levels – hovering within the same narrow range since 2009.  According to the data, an estimated 13.5 million “zero-dose” children did not receive a single vaccine in their first year during 2025. While these represent nearly 750 000 fewer children than the previous year, progress is offset by a rising number of children who start the schedule and do not complete it. Most of these children live in countries where national immunization programmes receive support from Gavi, the Vaccine Alliance.  Globally, 7.3 million infants are estimated to have received their first DTP dose but dropped out before receiving their first measles dose. This drop-out rate contributed to stalled measles coverage with 84% of children receiving the first measles dose (MCV1) and 77% receiving the second dose (MCV2). Both figures fall far short of the 95% threshold required to prevent outbreaks of this highly contagious virus. Consequently, 57 countries reported large or disruptive measles outbreaks in 2025.  “Governments and health workers have helped global vaccination rates bounce back after dropping significantly during the COVID-19 pandemic," said UNICEF Executive Director Catherine Russell. "But millions of vulnerable children are still being left unprotected due to conflict, displacement, and poverty.  We must reach every child, and we must rebuild trust where it is fraying. No child should suffer from a disease that a simple vaccine can prevent.” Data from 195 countries show that 100 countries have maintained at least 90% coverage with three doses of DTP vaccine since 2019, with little progress in expanding this group. Of the countries below 90% coverage in 2019, 30 improved their rates over the past six years, but 65 countries are stagnating or falling behind, including 13 fragile, conflict-affected or vulnerable countries (FCV). Compared to their 2019 baselines, the Americas and South-East Asia have fully recovered and improved their performance, with the latter now the highest performing region. While Africa, the Eastern Mediterranean, and Europe regions saw gains last year, their coverage remains below pre-COVID-19 pandemic levels. By contrast, the Western Pacific experienced a decline, leaving it the region furthest below its 2019 baseline. Behind these global and regional averages are persistent threats that are driving variability and volatility in country-level vaccination coverage. More than half of all zero-dose children live in FCV settings, even though they account for only about a third of the world’s child population. In these settings, immunization programmes are often strained by political upheaval, insecurity, or chronic underfunding. For example, in a single year, Syria lost 6 percentage points on DTP1 coverage and 12 points on MCV1. However, Sudan recorded the largest single-country gain globally last year, increasing DTP1 coverage by 35 percentage points and lifting MCV1 coverage by 22 points, demonstrating what is possible when access to services improves even amid ongoing conflict. In middle- and high‑income countries, even where vaccines are fully accessible, coverage is slipping amid shifting political commitment, structural challenges or rising hesitancy. For example, South Africa's DTP1 coverage has fallen 20 percentage points since 2019 and continued to decline in 2025. After the largest increase in MCV1 coverage in the region in 2024, Bosnia and Herzegovina saw a 23-point drop in the past year. “Every child, whether born into wealth or poverty, peace or conflict, deserves the lifegiving protection that vaccines provide. Immunization is one of the most cost-effective, most equitable, and most reliable interventions for protecting children’s health and well-being,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Our greatest security begins with ensuring that everyone, wherever they may live, is protected from deadly diseases that vaccines have the power to prevent.”  Over the past 25 years, sustained investments from governments and partners, commitments from communities, strengthened programmes, and broad public trust have reduced the annual number of zero-dose children by 40%. For example, in countries supported by Gavi, children today are protected against more diseases than ever before, with 74% average coverage today across a full course of WHO-recommended vaccines. “The historic levels of immunization that we are seeing across lower income countries shows what can be achieved when all stakeholders work together towards a shared objective,” said Dr Sania Nishtar, CEO of Gavi, the Vaccine Alliance. “As Gavi heads into a new five-year period, our great challenge now will be to maintain this momentum in the face of funding constraints, geopolitical uncertainty, and increasing outbreaks – while working harder to reach those children that still do not have access to immunization.”  However, the foundations that enabled progress are now under significant strain. The full impact of cuts to international health financing announced over the past two years is not yet reflected in these estimates, but the data systems needed to track that impact and protect against backsliding are themselves showing strain. According to the data, only 18 national immunization surveys were undertaken and submitted this round, down from 50 in 2024 and an average of 33 per year between 2015 and 2019. Weakening investments in the data systems needed to find and reach children who are missing out on vaccines will lead to outbreaks and deaths that could have been prevented, warn the agencies.   WHO and UNICEF are working with Gavi, the Vaccine Alliance and other partners to deliver the global Immunization Agenda 2030 (IA2030) goal to ensure vaccines reach everyone, everywhere, at every age, yet the world is further off track to reach the global target of reducing zero-dose children. To make this sharp course correction and bridge the critical gap, WHO and UNICEF call on governments and relevant partners to: strengthen immunization in conflict and fragile settings to reach and retain children; counter false and misleading health information and fully support vaccine uptake acceleration; increase and sustain domestic and global funding for immunization programmes and partnerships, including Gavi; and invest in stronger data and disease surveillance systems to drive and guide high-impact immunization programme strengthening efforts. Notes to editors:  Download multimedia content here. Access the WHO dataset: Global dashboard, country profiles, and additional resources   Access the UNICEF dataset: Overview page, Full datasets, Data visualisation, Regional data visualisation, Country profiles   WUENIC estimates, including historical data, are revised annually as new country data become available. Figures in this release should not be compared against previous years' published reports.  Based on country-reported data, the WHO and UNICEF estimates of national immunization coverage (WUENIC) provide the world’s largest and most comprehensive dataset on immunization trends for vaccinations against 13 diseases given through regular health systems  – normally at clinics, community centres, outreach services, or health worker visits. For 2025 data were provided from 185 countries.  WHO and UNICEF are working with Gavi, the Vaccine Alliance and other partners to deliver the global Immunization Agenda 2030 (IA2030), a strategy for all countries and relevant global partners to achieve set goals on preventing diseases through immunization and delivering vaccines to everyone, everywhere, at every age. About UNICEF  UNICEF, the United Nations agency for children, works to protect the rights of every child, everywhere, especially the most disadvantaged children and in the toughest places to reach. Across more than 190 countries and territories, we do whatever it takes to help children survive, thrive, and fulfil their potential.  For more information about UNICEF and its work, please visit: www.unicef.org   About WHO  Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the United Nations’ agency for health that connects nations, partners and people in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to support all countries to promote, provide and protect health.  “Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide.

WHO News (English)

El Salvador validated by WHO as having eliminated trachoma as a public health problem

The World Health Organization (WHO) has validated El Salvador as having eliminated trachoma as a public health problem. Trachoma is the world's leading infectious cause of blindness.

WHO News (English)

WHO calls for urgent action as new cancer cases are projected to nearly double by 2050

Millions of people are facing physical, emotional and financial toll of cancer, a disease that claims more than 26 000 lives every day, according to a report released today by the World Health Organization (WHO). With an estimated 20.6 million new cases and close to 10 million deaths annually, cancer remains the second leading cause of death globally, after cardiovascular disease.

WHO News (English)

WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing

Today, the World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL). The test detects the virus by identifying its genetic material in blood samples, helping confirm infection rapidly and accurately. WHO’s EUL procedure assesses the quality, safety and performance of essential health products based on the available evidence, while ensuring they meet minimum international standards and address the needs of low- and middle-income countries. Through this mechanism, WHO aims to accelerate access to reliable diagnostic tools for early case detection, timely clinical care, disease surveillance and effective outbreak response. The EUL also supports United Nations procurement agencies and governments in making informed decisions about the procurement and use of these products in public health emergency settings. "Public health emergencies require not only speed, but also confidence that the health products being used meet standards for quality, safety and performance," said Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data. "During a fast-moving outbreak, timely access to quality-assured diagnostic tests can make a critical difference in containing transmission. Through this Emergency Use Listing, WHO is helping countries access trusted diagnostic tools more rapidly so that they can respond more effectively.” On 17 May 2026, WHO Director-General Dr Tedros Adhanom Ghebreyesus declared a public health emergency of international concern over the outbreak of Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo, with cases in Uganda. Less than two weeks later, WHO launched a call for manufacturers of IVDs for Bundibugyo virus to submit Expressions of Interest for Emergency Use Listing. The listing comes at a critical time as countries respond to the largest recorded outbreak of Ebola disease caused by BDBV, which continues to expand. As of today, 1406 laboratory-confirmed cases and 438 deaths had been reported in the Democratic Republic of the Congo alone. With support from WHO and the Africa Centres for Disease Control and Prevention (Africa CDC), laboratory testing capacity has expanded from a limited number of sites – primarily Institut National de Recherche Biomédicale in Kinshasa and Goma, with an estimated combined capacity of approximately 200–400 tests per day – to a broader network of 10 laboratories across affected provinces, with a reported capacity of over 2000 tests per day. Rapid and reliable diagnosis remains essential to identify cases early, guide timely patient care, interruptand help bring outbreaks under control. WHO continues to work closely with manufacturers, global partners and countries to expand the availability of and access to safe, effective and quality-assured life-saving health products. Additional applications for BDBV IVDs submitted through the EUL procedure are currently under review. In parallel, WHO and Africa CDC, with partners including PATH, FIND and CHAI, and with support from Unitaid, are establishing a joint validation platform to rapidly evaluate the performance of a selection of diagnostic products, including laboratory-based molecular tests, near-point-of-care molecular tests and antigen rapid diagnostic tests. The platform will generate critically needed clinical evidence on the performance of these products in outbreak settings. Bundibugyo virus disease is a severe, often life-threatening disease caused by BDBV, one of three Ebola virus species known to cause large outbreaks in humans. The virus can spread from animals to humans and then from person to person through contact with a person sick or deceased and their infected bodily fluids or surfaces or items contaminated by these fluids. Information on active EUL applications for IVDs for BDBV nucleic acid detection can be found on these WHO webpages. About WHO Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to support countries to promote, provide and protect health. “Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide.

WHO News (English)

Patient enrolment begins in a scientific trial to identify the first effective treatments for Bundibugyo virus disease

In a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the PARTNERS clinical trial has opened enrolment today for patients in the Democratic Republic of the Congo.

WHO News (English)

655 million people still living without electricity underscore urgent need to deliver on universal energy access target

At a time when energy security and affordability have risen to the top of the development agenda, 655 million people globally still lack access to electricity, and two billion use polluting fuels and technologies for cooking putting their health and well-being at risk.

WHO News (English)

WHO urges scale up of newborn screening to improve early detection and care of birth defects

The World Health Organization (WHO) today calls on countries to expand newborn screening for birth defects, highlighting how early detection and treatment can save lives and reduce lifelong disability for millions of children. A new WHO report, Strengthening capacity for newborn screening, diagnosis and management of birth defects, identifies newborn screening as an important opportunity to accelerate progress in child survival. Many conditions can be successfully treated if identified early after birth. These include congenital hypothyroidism, sickle-cell disease, hearing impairment and some metabolic disorders. Yet millions of children are still diagnosed too late or never receive treatment at all. Worldwide, an estimated 8 million babies are born with a birth defect each year, and birth defects now account for almost 8% of all deaths among children under five. An estimated 90% of children born with serious birth defects live in low- and middle-income countries, where access to screening, diagnosis and treatment remains limited. "No child should miss the chance for a healthy future because a congenital condition was not detected early enough," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "Around the world, countries are showing that newborn screening for one or more conditions can save lives, prevent disability, and give a newborn the best opportunity to fulfil her or his potential ."The gap between countries is stark: some countries screen all newborns for more than 50 conditions, while others are unable to screen for any. WHO encourages every country to begin newborn screening — starting with a priority condition in the country and progressively expanding as capacity grows. The report shows that birth defects account for a growing proportion of under-five deaths in many regions. Between 2000 and 2023, the proportion of under-five deaths attributable to birth defects increased from 1% to 4% in sub-Saharan Africa and from 3% to 11% in South Asia. Part of this shift reflects genuine progress in the reduction of deaths from infectious and other preventable causes. The WHO report aims to support ministries of health, especially in low- and middle-income countries, to prioritize conditions for newborn screening depending on the country context. It showcases countries across Africa, Asia and the Americas that are already demonstrating the successful integration of large-scale newborn screening programmes into routine health services: Argentina: Increased newborn screening coverage to nearly universal levels. Brazil: Expanded nationwide screening for multiple life-threatening conditions. Egypt:  The ‘newborn care pathway’ integrates universal newborn screening for hearing and congenital hypothyroidism into its primary health care services. India: The national programme has screened more than 28 million children over three years, identifying approximately 900,000 children with a birth defect and connecting them with diagnosis, treatment and support, including long term care and rehabilitation services through district early intervention centres. Philippines: A programme that began as a pilot in 24 hospitals now screens newborns for 29 conditions through more than 7000 facilities nationwide. All conditions screened for have diagnostic and management pathways within the national health system. Newborn screening is covered by national health insurance and mandated by law. Sri Lanka: Newborn screening is integrated into routine care and includes visible birth defects and congenital hypothyroidism. Around 80% of newborns are now screened for congenital hypothyroidism. Uganda: A state-led programme for sickle-cell disease in high burden areas identifies affected infants early and provides them with lifesaving treatment and long-term follow-up care. WHO is urging governments to integrate newborn screening, diagnosis and treatment into routine health services and universal health coverage programmes, beginning with conditions that are country priorities, and that can be effectively detected and feasibly managed within their health system. The report was informed by a global WHO consultation bringing together government representatives, technical experts, clinicians, researchers, professional associations, civil society organizations and families affected by birth defects to identify priorities for strengthening newborn screening, diagnosis and long-term care. About WHO Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the United Nations’ agency for health that connects nations, partners and people in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to support all countries to promote, provide and protect health. “Together for health. Stand with science”, the theme of World Health Day 2026, marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide.

WHO News (English)

WHO issues comprehensive guidelines on filovirus disease, including Ebola and Marburg disease

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World Health Organization (WHO) has released its first comprehensive guidelines for the clinical management of filovirus disease which include all types of Ebola and Marburg viruses. The new guidelines highlight the importance of early supportive care to improve patient survival and health outcomes, outlining 16 evidence-based recommendations.

WHO News (English)

Open letter to leaders of G7, G20, BRICS and all nations on finalizing the WHO Pandemic Agreement’s Pathogen Access and Benefit Sharing annex

Dear Leaders of the G7, the G20, BRICS and of all nations, We write to you together, from Geneva and from Brasília, with one shared conviction: that the world must finish what it started, and that you can help it do so. We begin not with an institution or an annex, but with a memory the whole world shares. Not so long ago, our hospitals overflowed. Families said goodbye to the people they loved through glass, or by telephone, or not at all. Children lost grandparents. Doctors and nurses, exhausted beyond anything we had a right to ask of them, kept going anyway. Estimates from WHO and others put the lives lost at up to twenty million. Humanity promised itself, in the rawness of that grief, that it would not face such a day again unprepared. A little over a year ago, the world kept the first part of that promise. After the deadliest pandemic in a century, the nations of the world chose cooperation over division and adopted the WHO Pandemic Agreement to strengthen how countries can work together to prevent, prepare for, and respond to pandemics. In a divided world, that outcome was not to be taken for granted. It was an act of hope, and an act of faith in one another. We write to you now because that hope is not yet fulfilled, and because it lies within your hands to help fulfil it. One piece remains. To respond to future pandemics in time, countries must be able to quickly identify pathogens with pandemic potential and share their genetic information and material so scientists can develop tools: the tests, the treatments, the vaccines that decide who lives and who does not. The system that makes this possible, fairly and on equal footing, is the Pathogen Access and Benefit-Sharing annex. It is the last piece of the puzzle, not only for the Pandemic Agreement but for everything WHO and Member States have built from the hard lessons of COVID-19. Until it is finished, the Agreement cannot enter into force. The promise stays unkept. We will not pretend the road has been easy. When Member States closed their most recent session on the first of May, they had made real progress, but agreed that more time was needed. The hardest questions, including how the benefits of shared pathogens are defined and shared, how the system is governed, and how equity is guaranteed on equal footing, are difficult for a reason. They are the very questions that went unanswered last time, while people who could have been protected were not. The world is wrestling with them now precisely because they matter so much. Negotiators will meet again from 6 to 17 July. We believe in them, and we have seen their dedication up close. But we also know there are moments when good people, doing their best around a negotiating table, need their leaders to lift their eyes to the horizon. This is one of those moments, and it is yours. So we come to you, plainly, with three requests. First, political will at the highest level. The remaining issues will not be solved by technical effort alone. They need the clear signal that only a head of government can give: that finishing this annex is a national priority, and that your negotiators may reach for consensus with courage rather than caution. Solidarity is our best immunity, but solidarity has to be chosen, and it has to be chosen at the top. We know, too, that you may be asked if the Pandemic Agreement compromises state sovereignty. It does not, and the PABS annex, as an integral part of it, will not either. Article 22, paragraph 2 says so plainly: nothing in the Agreement gives WHO any authority to direct or alter a country’s laws or policies, or to require measures such as lockdowns, travel restrictions or vaccination mandates. Those decisions remain with sovereign states. So we ask you, concretely, to instruct your negotiators to come to the July session ready to conclude, and to give them the flexibility to close the remaining gaps and finalize the annex in this round. Second, a spirit of equity. The PABS system rests on a simple, fair bargain: those who share dangerous pathogens quickly must be able to trust that the vaccines and treatments born from that sharing will reach their own people too. Every one of us has a stake on both sides of it. When Brazil held the G20 presidency in 2024, it led the G20 to recognize, for the first time, inequality as a driver of pandemics. This is not charity, and it is not only conscience. It is also strategy: PABS exists to stop an outbreak at its source, and containing a threat where it begins is far cheaper, in lives and in resources, than fighting a pandemic once it has spread to every continent. A virus left to burn anywhere will, in time, find everyone. There is a further reason equity matters, one that governments and industries everywhere will grasp at once: predictability. Today the rules for accessing a pathogen and sharing what flows from it are improvised case by case, often mid-crisis. PABS replaces that with a single framework known in advance, stable rules that let laboratories and partners across the world move at the speed an outbreak demands. Legal certainty does not compete with equity; it makes equity work. We ask you to ensure the annex carries equity in its operational detail, not only in its preamble, so that access and benefit-sharing are guaranteed in practice. Third, a sense of urgency. The next pandemic will not wait for us. Scientists estimate there is close to a one in four chance of another pandemic within the coming decade, and the ground beneath our old assumptions is shifting. Climate change, changing land use and evolving agriculture are redrawing the map of where dangerous pathogens emerge; the comfortable belief that outbreaks begin only in distant places is no longer true, and future hotspots may arise in or near your own countries. At the same time, advances in biotechnology, matched unevenly by biosafety, raise the risk of accidental or deliberate release. None of these dangers respect a border. So we ask you to treat 17 July as a deadline, not a milestone, and to say so publicly, sending your negotiators, and the world, the unambiguous signal that this is the round in which the work is finished. And we already know the price of being unready. The last pandemic took lives on a staggering scale, with estimates from WHO and others putting the toll at up to twenty million, and the International Monetary Fund estimates it cost the world economy over thirteen trillion dollars in lost output, a loss borne in every nation, in shuttered businesses, broken supply chains and a generation of disrupted schooling. Against that, the investment in a system that catches an outbreak early is small. As we write these words, an Ebola outbreak is being fought across two countries, with no approved vaccine and no cure, by responders who are risking their own lives to protect strangers. That is not a distant abstraction. It is happening now. Every month this annex stays unfinished is a month the world is less ready than it could be, and people are less safe than they deserve to be. The nations of the world, together, have stood at every great turning point in the story of human health. Together we helped wipe smallpox from the earth. We pushed polio to the very edge of history. We turned back the tide of HIV, tuberculosis and malaria, and in doing so helped save more lives than any of us will ever be able to count. Finishing this Agreement is not a departure from that legacy. It is its natural next chapter, and it is within reach. We made a promise to the millions we lost, and to the families who carry their absence still. Let us be the generation that keeps that promise. Finalizing this Agreement, through a shared commitment to one another, is our collective promise to protect humanity. Let us keep it, together, and in time. With respect, and in the shared cause of protecting human life, Luiz Inácio Lula da Silva President Federative Republic of Brazil Dr Tedros Adhanom Ghebreyesus Director-General World Health Organization

WHO News (English)

Safe blood supply improves as voluntary donations exceed 85%, but many people still lack access

New data from the World Health Organization (WHO) show sustained progress towards safer blood supplies globally but also highlight persistent inequalities in access to safe blood and weaknesses in governance, financing and regulation of blood systems.

WHO News (English)

Africa CDC and WHO launch joint continental Ebola response plan

The Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) today launched a joint continental preparedness and response plan on the ongoing Ebola outbreak caused by the Bundibugyo virus. The plan aims to raise US$ 518 million to support African countries together with partners to prepare for, rapidly detect and respond to the outbreak. The six-month plan, covering June to November 2026, brings together governments, partners and communities under a unified ‘One Response’ approach to strengthen outbreak response measures, including emergency coordination, disease surveillance, laboratory testing, infection prevention and control, clinical care, community engagement, research, logistics and support for essential health services. The plan complements national response plans launched by the Governments of the Democratic Republic of the Congo and Uganda. “The only way to beat this outbreak is through close partnership, working together under the leadership of the affected countries in one coordinated effort, guided by a simple principle: one plan, one budget, one team,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Containing Ebola depends on political commitment, sustained financing, and the trust and engagement of communities. This plan places communities at the centre, because without their participation, contact tracing falters, safe care is delayed, and transmission continues.” Dr Jean Kaseya, Director-General of Africa CDC, said: “Ebola moves fast. Africa must move faster. This joint plan gives the continent a clear path to act with speed and unity: to save lives, support the affected countries and protect neighbouring communities. With Member States, WHO and partners, Africa CDC is turning commitment into action and resources into response for the communities at risk.” The plan also focuses on protecting vulnerable populations, strengthening cross-border collaboration, and supporting countries to respond quickly to new cases. At a time when there are no licensed vaccines or therapeutics specifically approved for the Bundibugyo species of Ebola, the plan aims to strengthen health systems to ensure resilience even as countries respond to acute health emergencies. Implementation of preparedness and response activities is already underway across affected and at-risk countries. Furthermore, in 10 priority countries critical measures are being strengthened to enhance public health emergency preparedness and ensure early detection and swift response. The plan emphasizes the need to maintain support for other ongoing health emergencies, including mpox, cholera and measles, to prevent disruptions to critical response efforts and safeguard progress towards stronger, more resilient health systems. This coordinated effort comes as response operations accelerate in the Democratic Republic of the Congo, where authorities, with support from Africa CDC, WHO and partners, are ramping up efforts to curb the spread of the virus and end the outbreak. Africa CDC and WHO urge Member States to strengthen screening and public health measures at points of entry and enhance cross-border coordination and solidarity to support a timely, effective and evidence-based response to the outbreak. Through the joint preparedness and response plan, the continent is mobilising its collective expertise and resources to reinforce response measures, acting as one to control the outbreak and protect communities across the region. Its successful implementation will require strong political commitment, sustained investment and close collaboration among governments, health workers, communities and partners. Drawing on lessons learned from previous Ebola outbreaks and recent public health emergencies, the plan also provides a pathway to broadly strengthen Africa’s capacity to prevent, detect and respond to future health threats while protecting lives and livelihoods. About Africa CDC The Africa Centres for Disease Control and Prevention (Africa CDC) is the public health agency of the African Union. As an autonomous institution, Africa CDC supports AU Member States to strengthen health systems, improve disease surveillance, and enhance emergency preparedness and response. Africa CDC works with Member States, Regional Economic Communities and partners to prevent, detect and respond quickly and effectively to disease threats and outbreaks across the continent. For more information, visit www.africacdc.org and follow Africa CDC on LinkedIn, X, Facebook and YouTube. About WHO Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. “Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide.

WHO News (English)

Unsafe food causes 866 million illnesses and 1.5 million deaths annually, young children at highest risk

Children aged less than five years face almost three times the risk of illness from unsafe food than older children and adults, according to new estimates released today by the World Health Organization (WHO).

WHO News (English)

Seventy-ninth World Health Assembly – Daily update: 23 May 2026

Summary of discussions of 23 May at the Seventy-ninth World Health Assembly.

WHO News (English)

Seventy-ninth World Health Assembly – Daily update: 22 May 2026

Summary of discussions of 22 May at the Seventy-ninth World Health Assembly.

WHO News (English)

First meeting of the IHR Emergency Committee regarding the epidemic of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo and Uganda 2026 – Temporary recommendations

The Committee’s advice aligned with the determination by the WHO Director-General that the event constitutes a public health emergency of international concern (PHEIC), but does not meet the criteria for pandemic emergency. The DG, considering the advice of the Committee, he is hereby issuing the following temporary recommendations to all States Parties.

WHO News (English)

Seventy-ninth World Health Assembly – Daily update: 21 May 2026

Summary of discussions of 21 May at the Seventy-ninth World Health Assembly.

WHO News (English)

Seventy-ninth World Health Assembly – Daily update: 20 May 2026

Summary of discussions of 20 May at the Seventy-ninth World Health Assembly.

WHO News (English)

Seventy-ninth World Health Assembly – Daily update: 19 May 2026

Summary of discussions of 19 May at Seventy-ninth World Health Assembly

WHO News (English)

Seventy-ninth World Health Assembly honours global champions advancing primary health care

Today, the World Health Assembly recognized individuals and institutions whose contributions to global health have gone far beyond the call of duty. Six laureates representing diverse backgrounds and contexts were honoured by the President of the Seventy-ninth World Health Assembly, Dr Víctor Elias Atallah Lajam of Dominican Republic, together with representatives of the foundations that have provided these prizes over the last 40 years, and WHO Director-General Dr Tedros Adhanom Ghebreyesus. The 2026 prizes celebrate the remarkable dedication of the six awardees to advancing primary health care, reducing inequities and bringing the goal of health for all closer to reality. Selected by WHO’s Executive Board in February 2026, the 2026 laureates reflect a shared commitment to improving health outcomes through scientific excellence, innovation and community outreach. Their work ranges from strengthening primary health care systems and advancing disease control to empowering communities and expanding access to essential services for the most vulnerable populations. This year marks 20 years since the passing of Dr LEE Jong-wook, WHO’s sixth Director-General, who passed away unexpectedly during the World Health Assembly in 2006. One of the prizes awarded today, the Dr LEE Jong-wook Memorial Prize for Public Health, honours his legacy and enduring contribution to global health. Winners of the 2026 public health prizes Sasakawa Health Prize The Banconi Community Health Association (ASACOBA), Mali Recognized for its pioneering role in strengthening community-based primary health care and empowering underserved populations through locally driven health services. United Arab Emirates Health Foundation Prize Dr Worawit Tontiwattanasap, Thailand Recognized for transforming access to health services for rural, stateless and cross-border populations through outreach services, training and policy advocacy. State of Kuwait Health Promotion Foundation’s His Highness Sheikh Sabah Al-Ahmad Al-Jaber Al-Sabah Prize for the Promotion of Healthy Ageing Professor Bruno Vellas, France Recognized for advancing and developing innovative, community-based approaches to care for older people. SingHealth, Singapore Recognized for its integrated, cross-sectoral and community-centred strategies supporting healthy ageing and age-friendly environments. Dr LEE Jong-wook Memorial Prize for Public Health Professor Mohammad Abul Faiz, Bangladesh Recognized for his lifelong contribution to public health, particularly in addressing diseases affecting rural, poor and marginalized populations. Nelson Mandela Award for Health Promotion Dr Amr Mohamed Kandeel, Egypt Recognized for his leadership in building a resilient, prevention-oriented public health system integrating disease control, digital innovation and equity. About WHO public health prizes and awards Every year, during the World Health Assembly, public health prizes and awards are presented to individuals and institutions from around the world for their outstanding contributions to public health. Public health foundation prizes are awarded following nominations submitted by WHO Member States and former laureates. Selection panels composed of representatives of the prize foundations and WHO Executive Board Members review candidates and make recommendations. The WHO Executive Board designates the winners each year, and the awards are presented during a plenary session of the World Health Assembly. Over the past 15 years, more than 80 laureates from over 50 WHO Member States have received public health prizes. In 2026, nearly 100 nominations were submitted from across all six WHO regions, reflecting a significant increase in global engagement in recognizing public health excellence. About WHO  Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life.  We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. “Together for health. Stand with science”, the theme of World Health Day 2026 marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide.

WHO News (English)

World Health Assembly opens in Geneva, Switzerland

The Seventy-ninth session of the World Health Assembly (WHA79) opened in Geneva, Switzerland today, with the election of Dr Víctor Elías Atallah Lajam of the Dominican Republic as the President of the Health Assembly.    The elected Vice-Presidents are Dr Mohamed Ali Al-Ghouj of Libya, Dr Assa Badiallo Touré of Mali, Mrs Katarzyna Drążek -Laskowska of Poland, Mrs Neesha Mehta of Nepal, and Mr Elias Kapavore of Papua New Guinea. Dr Timur Sultangaziyev of Kazakhstan and Dr Kwabena Mintah Akandoh of Ghana are the Chairs of the Committee A and Committee B, respectively.  During the high-level welcome, H.E. Elisabeth Baume‑Schneider, Federal Councillor of the Swiss Confederation, addressed the Health Assembly on behalf of the host country, followed by remarks from H.E. John Dramani Mahama, President of Ghana and Special Guest of Honour.    Delegates also heard video messages from H.E. António Guterres, United Nations Secretary‑General, H.E. Ahmad Al Sharaa, President of the Syrian Arab Republic, and H.E. Mia Mottley, Prime Minister of Barbados.  Dr Tedros Adhanom Ghebreyesus, WHO Director‑General, addressed the Assembly and then presented the Awards for Global Health to Dr Tore Godal, Dr Merceline Dahl-Regis, Dr Mike Ryan and Dr Heba El Sewedy, recognizing their lifetime achievements and exceptional contributions to improving the health and well-being of communities worldwide.  Special Guest, H.E. Pedro Sanchez, Prime Minister of Spain, addressed the Assembly at the conclusion of the afternoon session in the Plenary.

1 / 2다음 →